Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Comirnaty
Active Ingredient: Tozinameran 0.1mg/mL
Dosage Form: Suspension for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Pfizer Manufacturing Belgium NV, Puurs-Sint-Amands, Belgium
Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany
Patheon Italia S.p.A, Milan, Italy
BioNTech Manufacturing Marburg GmbH, Marburg, Germany
Mibe GmbH Arzneimittel, Brehna, Germany
Allergopharma GmbH & Co. KG, Reinbek, Germany
   
Product: Comirnaty (3mcg/0.2mL dose)
Active Ingredient: Tozinameran 0.1mg/mL
Dosage Form: Concentrate for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Manufacturing Belgium NV, Puurs-Sint-Amands, Belgium
   
Product: Comirnaty (10mcg/0.2mL dose)
Active Ingredient: Tozinameran 0.1mg/mL
Dosage Form: Concentrate for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Pfizer Manufacturing Belgium NV, Puurs-Sint-Amands, Belgium
   
Product: Comirnaty
Active Ingredient: Tozinameran 0.5mg/mL
Dosage Form: Concentrate for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Novartis Pharma Stein AG, Stein, Switzerland
Pfizer Manufacturing Belgium NV, Puurs-Sint-Amands, Belgium
Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany
Baxter Oncology GmbH, Halle-Kunsebeck Westfalen, Germany
Patheon Italia S.p.A, Milan, Italy
Polymun Scientific Immunobiologische Forschung GmbH, Klosterneuburg, Austria
Siegfried Hameln GmbH, Hameln, Germany
Delpharm Saint Remy, Saint Remy Sur Avre, France
Catalent Anagni SRL, Anagni, Italy
BioNTech Manufacturing Marburg GmbH, Marburg, Germany
Mibe GmbH Arzneimittel, Brehna, Germany
Allergopharma GmbH & Co. KG, Reinbek, Germany


Dated this 7th day of November 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).